Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer

NCT03994107 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Pegylated Liposomal Doxorubicin
DRUG: Albumin-bound paclitaxel
DRUG: Trastuzumab

Sponsor

Peking Union Medical College

Collaborators

[object Object]